Lisavanbulin (BAL-101553) didrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862) . Lisavanbulin didrochloride exhibits antitumor activity, especially in tumors that express high levels of end-binding protein 1.
References:
[1]. Spriano F, et al. Assessment of lisavanbulin (BAL101553) as an anti-lymphoma agent[J]. bioRxiv, 2023: 2022.12. 31.521730.
















